AGEN Stock Analysis: Buy, Sell, or Hold?
AGEN - Agenus Inc.
$5.01
0.01 (0.20%)
▲
5d:
+49.55%
30d:
+68.12%
90d:
+7.97%
HOLD
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 10, 2026
22d
Get Alerted When AGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: AGEN is 14.6% above its trading range ($4.37). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: AGEN is 14.6% above its trading range ($4.37). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: AGEN is currently trading at $5.01, which is considered extended relative to its 30-day fair value range of $2.71 to $4.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -31.3) compared to its historical average (5.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AGEN is showing sideways momentum. Immediate support is located at $3.10, while resistance sits at $8.70.
Market Sentiment: AGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+498.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AGEN is showing sideways momentum. Immediate support is located at $3.10, while resistance sits at $8.70.
Market Sentiment: AGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+498.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.71 -
$4.37
Company Quality Score
60/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
52.4%
Protect Your Profits
Holding AGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 498.8% below Wall St target ($30.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$2.71 -
$4.37
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.10
Resistance Level
$8.70
Current Trend
Sideways
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.31
Wall Street Target
$30.00
(+498.8%)
Revenue Growth (YoY)
40.2%
Profit Margin
52.2%
PE vs Historical
-31.3 vs 5.1
CHEAP
Share & Embed Analysis
Last updated: July 18, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 47 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 66 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 64 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 58 HOLD |
Advanced AGEN Option Strategies
Professional options setups generated by AI based on today's AGEN price and gamma walls.
